Helix BioPharma Corp. Announces the Receipt of Subscription Agreements for a … – Wall Street Journal

Helix BioPharma Corp. Announces the Receipt of Subscription Agreements for a
Wall Street Journal
(TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has received private placement subscription agreements for common shares and warrants for

and more

…read more

Scroll to Top